Evaluation of different models of tumor spheroid generation with CAL27 cells
DOI:
https://doi.org/10.53660/692.prw2209Palavras-chave:
3D culture, Skin cancer, Alternative methods, Tumor cell, cancerResumo
In cancer research, three-dimensional cell culture models have become useful tools for investigating the tumor microenvironment, cancer stages, and the search for new therapeutic targets. In this sense, the aim of this study was to contribute with a tumor spheroid model of squamous cell carcinoma (CAL27) to be used for studies of this type of cancer and new therapeutic alternatives. For this, two methods of spheroid generation were tested, a 96-well plate model coated with agarose and a cylindrical microwell model developed using 9x9 size micromolds with 800 μm diameter that fit into 24-well plates (3D Petri Dish®). The microwell generation model showed more promising results, generating spheroids up to 183.97 ± 15 µm in diameter. Although the analysis of spheroid size and growth kinetics was superior to other assays, the marking of the necrotic center produced essential images for confirmation of the generation of the three-dimensional model, as well as the results of the cytotoxicity assay. The results presented here contribute to the progress of the use of 3D cell culture systems for the study and search for responses to agents that may act on squamous cell carcinoma and provide a viable alternative for cancer research laboratories.
Downloads
Referências
ARANHA, E. S. P. et al. 22β-hydroxytingenone reduces proliferation and invasion of human melanoma cells. Toxicology in Vitro, v. 66, 1 ago. 2020. https://linkinghub.elsevier.com/retrieve/pii/S0887233319307015
ARANHA, E. S. P. et al. 22β-hydroxytingenone induces apoptosis and suppresses invasiveness of melanoma cells by inhibiting MMP-9 activity and MAPK signaling. Journal of Ethnopharmacology, v. 267, 1 mar. 2021. https://linkinghub.elsevier.com/retrieve/pii/S0378874120334930
ASTASHKINA, A.; MANN, B.; GRAINGER, D. W. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacology & Therapeutics, v. 134, n. 1, p. 82–106, abr. 2012. https://linkinghub.elsevier.com/retrieve/pii/S0163725812000022
BRASIL. Estimativa 2023: incidência de câncer no Brasil. Available at: <https://www.inca.gov.br/publicacoes/livros/estimativa-2023-incidencia-de-cancer-no-brasil>. Accessed on: 10 jun. 2023.
BRÜNINGK, S. C.; RIVENS, I. 3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments. Scientific Reports, v. 10, n. 1653, 2020. https://doi.org/10.1038/s41598-020-58569-4
CHAMOLI, A. et al. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncology, v. 121, 1 out. 2021. https://linkinghub.elsevier.com/retrieve/pii/S136883752100556X
COSTARD, L. S. et al. Influences of the 3D microenvironment on cancer cell behaviour and treatment responsiveness: A recent update on lung, breast and prostate cancer models. Acta Biomaterialia, 15 set. 2021. https://linkinghub.elsevier.com/retrieve/pii/S1742706121000507
DA SILVA, F. M. A. et al. Chemical constituents from Salacia impressifolia (Miers) A. C. Smith collected at the Amazon rainforest. Biochemical Systematics and Ecology, v. 68, p. 77–80, 1 out. 2016. https://linkinghub.elsevier.com/retrieve/pii/S030519781630165X
DÄSTER, S. et al. Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment. Oncotarget. Available at: <https://doi.org/10.18632/oncotarget>. Accessed on: 14 abr. 2023.
FENNEMA, E. et al. Spheroid culture as a tool for creating 3D complex tissues. Trends in Biotechnology, v. 31, n. 2, p. 108–115, fev. 2013. https://linkinghub.elsevier.com/retrieve/pii/S0167779912002223
FERLAY, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer, v. 144, n. 8, p. 1941–1953, 2019. https://onlinelibrary.wiley.com/doi/10.1002/ijc.31937
FRIEDRICH, J. et al. Spheroid-based drug screen: Considerations and practical approach. Nature Protocols, v. 4, n. 3, p. 309–324, 2009. https://www.nature.com/articles/nprot.2008.226
GUNTI, S. et al. Organoid and Spheroid Tumor Models: Techniques and Applications. Cancers, v. 13, n. 4, p. 874, 19 fev. 2021. https://www.mdpi.com/2072-6694/13/4/874
HUANG, Z.; YU, P.; TANG, J. Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model. OncoTargets and therapy, v. 13, p. 5395, 2020. https://www.dovepress.com/characterization-of-triple-negative-breast-cancer-mda-mb-231-cell-sphe-peer-reviewed-article-OTT
ISHIGURO, T. et al. Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications. Cancer Science, v. 108, n. 3, p. 283–289, 1 mar. 2017. https://onlinelibrary.wiley.com/doi/10.1111/cas.13155
IVANOV, D. P. et al. Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres. PLoS ONE, v. 9, n. 8, 13 ago. 2014. https://dx.plos.org/10.1371/journal.pone.0103817
KOROKNAI, V. et al. Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids. Pathology and Oncology Research, v. 26, n. 4, p. 2557–2566, 1 out. 2020. http://link.springer.com/10.1007/s12253-020-00837-9
LEE, K.-H.; KIM, T.-H. Recent Advances in Multicellular Tumor Spheroid Generation for Drug Screening. Biosensors, v. 11, n. 11, p. 445, 11 nov. 2021. https://www.mdpi.com/2079-6374/11/11/445
MAAS-SZABOWSKI, N.; STÄRKER, A.; FUSENIG, N. E. Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF- α. Journal of Cell Science, v. 116, n. 14, p. 2937–48, 2003. https://journals.biologists.com/jcs/article/116/14/2937/27275/Epidermal-tissue-regeneration-and-stromal
MBEUNKUI, F.; JOHANN, D. J. Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol, v. 63, n. 4, p. 571–582, 2009. http://link.springer.com/10.1007/s00280-008-0881-9
MEHTA, G. et al. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. Journal of Controlled Release, v. 164, n. 2, p. 192–204, 10 dez. 2012. https://linkinghub.elsevier.com/retrieve/pii/S016836591200404X
NATH, S.; DEVI, G. R. Three-Dimensional Culture Systems in Cancer Research: Focus on Tumor Spheroid Model. Pharmacol Ther., v. 163, p. 94–108, 2016. https://doi.org/10.1016/j.pharmthera.2016.03.013
NUNES, A. S. et al. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnology and Bioengineering, v. 116, n. 1, p. 206–226, 1 jan. 2019.. https://onlinelibrary.wiley.com/doi/10.1002/bit.26845
QUE, S. K. T.; ZWALD, F. O.; SCHMULTS, C. D. Cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology, v. 78, n. 2, p. 237–247, 1 fev. 2018. https://linkinghub.elsevier.com/retrieve/pii/S0190962217323253
RAMA-ESENDAGLI, D. et al. Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer. Molecular biology reports, v. 41, n. 5, p. 2885–2892, 2014. https://pubmed.ncbi.nlm.nih.gov/24469725/
REIJNDERS, C. M. A. et al. Development of a Full-Thickness Human Skin Equivalent in Vitro Model Derived from TERT-Immortalized Keratinocytes and Fibroblasts. Tissue Engineering - Part A, v. 21, n. 17–18, p. 2448–2459, 2015. https://www.liebertpub.com/doi/10.1089/ten.tea.2015.0139
SAKALEM, M. E. et al. Historical evolution of spheroids and organoids, and possibilities of use in life sciences and medicine. Biotechnology Journal, v. 16, n. 5, p. 2000463, 25 maio 2021. https://onlinelibrary.wiley.com/doi/10.1002/biot.202000463
SHIMIZU, I. et al. Treatment of Squamous Cell Carcinoma In Situ : A Review. Dermatologic Surgery, v. 37, n. 10, p. 1349–1411, 2011. https://journals.lww.com/00042728-201110000-00002
SONG, A. S.; NAJJAR, A. M.; DILLER, K. R. Thermally induced apoptosis, necrosis, and heat shock protein expression in 3D culture. Journal of Biomechanical Engineering, v. 136, n. 7, 2014. https://asmedigitalcollection.asme.org/biomechanical/article/doi/10.1115/1.4027272/472860/Thermally-Induced-Apoptosis-Necrosis-and-Heat
SPOERRI, L.; GUNASINGH, G.; HAASS, N. K. Fluorescence-Based Quantitative and Spatial Analysis of Tumour Spheroids: A Proposed Tool to Predict Patient-Specific Therapy Response. Frontiers in Digital Health, v. 3, 28 maio 2021. https://www.frontiersin.org/articles/10.3389/fdgth.2021.668390/full
STENZEL, K. et al. Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell Lines. Journal of Medicinal Chemistry, v. 60, n. 13, p. 5334–5348, 13 jul. 2017. https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01538
SUNG, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, v. 71, n. 3, p. 209–249, 4 maio 2021. https://onlinelibrary.wiley.com/doi/10.3322/caac.21660
VERJANS, E. T. et al. Three-dimensional cell culture models for anticancer drug screening: Worth the effort? Journal of Cellular Physiology, v. 233, n. 4, p. 2993–3003, 2018. https://onlinelibrary.wiley.com/doi/10.1002/jcp.26052
WHO. WHO report on cancer: setting priorities, investing wisely and providing care for all. Available at: <https://www.who.int/publications-detail/who-report-on-cancer-setting-priorities-investing-wisely-and-providing-care-for-all>. Accessed on: 20 jun. 2023.
ZANONI, M. et al. Anticancer drug discovery using multicellular tumor spheroid models. Expert Opinion on Drug Discovery, v. 14, n. 3, p. 289–301, 4 mar. 2019. https://www.tandfonline.com/doi/full/10.1080/17460441.2019.1570129
ZANONI, M. et al. Modeling neoplastic disease with spheroids and organoids. Journal of Hematology & Oncology, v. 13, n. 1, p. 97, 16 dez. 2020. https://jhoonline.biomedcentral.com/articles/10.1186/s13045-020-00931-0
ZHANG, K. et al. TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma. Cancer Cell International, v. 20, n. 1, 6 maio 2020. https://cancerci.biomedcentral.com/articles/10.1186/s12935-020-01224-9
